Chinese Neurosurgical Journal Highlights Gut–Brain Axis in Pituitary Tumor–Related Cognitive Decline
Hormonal dysregulation and gut microbiota alterations as potential contributors to cognitive dysfunction CHINA, March ...
ImmunityBio’s sBLA targets BCG-unresponsive papillary NMIBC without CIS, complementing the existing U.S. approval for CIS ...
News-Medical.Net on MSN
Hormonal imbalance and gut microbes linked to cognitive deficits in patients with PitNETs
Pituitary neuroendocrine tumors (PitNETs) are commonly associated with visual disturbances and endocrine abnormalities; however, many patients also experience cognitive deficits, particularly in ...
News Medical on MSN
STING agonists exert potent antitumor effects against nervous system tumors
The cGAS-STING signaling pathway has emerged as a major focus in cancer immunotherapy because it stimulates interferon production and enhances antitumor immune responses. However, despite strong ...
This CDC report detailed 46 cases of suspected donor-derived KSHV-related complications among 153 transplant recipients from 2021-2025, roughly five times the number of cases reported from 2016-2020.
Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...
Discover how Ayurveda reverses cancer using four pillars: food, lifestyle, herbs, and Panchakarma. Learn natural healing at ...
Obesity is now linked to at least 13 types of cancer, making it one of the most preventable cancer risk factors in the United ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Researchers have found hundreds of metabolic enzymes attached to human DNA inside the cell nucleus. Different tissues and cancers show unique patterns of these enzymes, forming a “nuclear metabolic ...
Researchers have found evidence of nuclear metabolic enzymes for the first time, contributing to our understanding of cancer ...
PARIS, FRANCE, 09 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik (tazemetostat) in all indications from all Ipsen markets. Ipsen's decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results